{"id":397930,"date":"2020-12-10T18:00:15","date_gmt":"2020-12-10T23:00:15","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=397930"},"modified":"2020-12-10T18:00:15","modified_gmt":"2020-12-10T23:00:15","slug":"investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\/","title":{"rendered":"INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Minerva Neurosciences, Inc.\u00a0"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK, Dec.  10, 2020  (GLOBE NEWSWIRE) &#8212; The law firm of <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KoP1LhUgu1f2zNR_UiZ7K91K7TSAPcPQ6GJk7VcjQlw8AeAx4vhlPgp2c9-68YAZBZMwU6r1tpB1ZBlkcNev7g==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Kirby McInerney LLP<\/a> announces that a class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts on behalf of those who acquired Minerva Neurosciences, Inc. (\u201cMinerva\u201d or the \u201cCompany\u201d) (NASDAQ: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PTufia0vKgjwOlRzn7au6ost87YWeoNc8vuIte2VJ2REqJajtCifZvxHWGH4tnE6-AhC9e8K7jpnoRL8RuiQpXeo7GRyds4AvYVOfhxczqKsqrdwq9YwHPouexHKP21x\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">NERV<\/a>) securities during the period from May 15, 2017 through November 30, 2020 (the \u201cClass Period\u201d). Investors have until February 8, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.<\/p>\n<p align=\"justify\">On December 1, 2020, Minerva announced the results of its meeting with the U.S. Food and Drug Administration concerning Minerva\u2019s attempt to submit a New Drug Application for roluperidone, to treat negative symptoms in schizophrenia. The FDA advised that an NDA submission based on Minerva&#8217;s current data from two studies \u201cwould be highly unlikely to be filed\u201d and that doing so would present \u201csubstantial review issues due to the lack of two adequate and well-controlled trials to support efficacy claims.\u201d On this news, Minerva\u2019s stock price fell $1.00 per share, or approximately 26%, to close at $2.89 per share on December 1, 2020.<\/p>\n<p align=\"justify\">This most recent development follows Minerva\u2019s May 29, 2020 announcement of the results of its Phase III clinical trial for the use of roluperidone to treat negative symptoms in schizophrenia. The Phase III study failed to show statistically significant differences from placebo on both the primary and key secondary endpoints. On this news, the Company\u2019s stock price fell $9.76 per share, or approximately 72.5%, to close at $3.71 per share on May 29, 2020.<\/p>\n<p align=\"justify\">If you acquired Minerva securities, have information, or would like to learn more about these claims, please contact <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zIALFyEks2pAhroUYn24Ui1MXFa3KWsWmdPtjO3ehbteOds4I4dS7wRQu7L-k4b85Wc4DN3kqkC-dz6yy70MRsNz6R7U3-hjzbeRQD0No7w=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Thomas W. Elrod<\/a> of Kirby McInerney at 212-371-6600, by email at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZjlXI1K_gZIxOlBQ2CEyRncTlhx_wJdWosuK1T6PrpaZvUp1fe0ljhKtZb8LRl39AxVYTWnXkXkZxgYLx6KpLSepFwh_DcKNjpSVram77Zk=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">investigations@kmllp.com<\/a>, or by filling out <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TRt6Ee6vAeUiUwFvIsZDGlzPMYA53fFgMm-VjqqAyT1YztFEY5KUIQYiVQ6C2AqOufNbljSwawgtR6DVH5G7Vrdr83psNqXjd62LC9cok2MuE7TYcaB2xRt9QrPXrlIy\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">this contact form<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=q8A__ojoz6e0YmKP1IqzOk_dHzJ9iz2ErNjtExaJIKL0-uy9fGP0VdzTNRQclIKJM6onqBBeKD9O8GD_4FK54A==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">,<\/a> to discuss your rights or interests with respect to these matters without any cost to you.<\/p>\n<p align=\"justify\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KoP1LhUgu1f2zNR_UiZ7K7CJb4eoUTZt0I25WsMWZ1QPADnsNulki4mS6AzTpFLnQ7GXjMfBG0YZnmWKWYDMMQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Kirby McInerney<\/a> is a New York-based plaintiffs\u2019 law firm concentrating in securities, antitrust, and whistleblower litigation. The firm\u2019s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney\u2019s website: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BXYegVMEcLIrqqVozlSTvh2ihkHHfszEDNYRyezoRezJeYhX6575c07cvxjojKW6B2DHzm7_X4RsHGIwSGbJ4g==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.kmllp.com<\/a>.<\/p>\n<p align=\"justify\">This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/p>\n<p>Contacts<\/p>\n<p>Kirby McInerney LLP<br \/>Thomas W. Elrod, Esq., (212) 371-6600<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZjlXI1K_gZIxOlBQ2CEyRncTlhx_wJdWosuK1T6PrpbT9CTB1luRQzMlmOZ0-SvVzKR8TyEOuNKPRdYFq5SBrpradI8RKd2lE-iZFDAHQmo=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">investigations@kmllp.com<\/a><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BXYegVMEcLIrqqVozlSTvqvP3jp4B2Sd17xV2Bo0MiYSGQk9r5UVs4tk-3W2R-ff5DJV5yULjdrY4lScXnKIww==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.kmllp.com<\/a><\/p>\n<p>\u00a0<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDU2MSMzODY2OTEzIzIwMjA2Njk=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/e618ecdc-3666-4702-aaa3-20a19a9431ef\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Dec. 10, 2020 (GLOBE NEWSWIRE) &#8212; The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts on behalf of those who acquired Minerva Neurosciences, Inc. (\u201cMinerva\u201d or the \u201cCompany\u201d) (NASDAQ: NERV) securities during the period from May 15, 2017 through November 30, 2020 (the \u201cClass Period\u201d). Investors have until February 8, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit. On December 1, 2020, Minerva announced the results of its meeting with the U.S. Food and Drug Administration concerning Minerva\u2019s attempt to submit a New Drug Application for roluperidone, to treat negative symptoms in schizophrenia. The &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Minerva Neurosciences, Inc.\u00a0&#8220;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-397930","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Minerva Neurosciences, Inc.\u00a0 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Minerva Neurosciences, Inc.\u00a0 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Dec. 10, 2020 (GLOBE NEWSWIRE) &#8212; The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts on behalf of those who acquired Minerva Neurosciences, Inc. (\u201cMinerva\u201d or the \u201cCompany\u201d) (NASDAQ: NERV) securities during the period from May 15, 2017 through November 30, 2020 (the \u201cClass Period\u201d). Investors have until February 8, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit. On December 1, 2020, Minerva announced the results of its meeting with the U.S. Food and Drug Administration concerning Minerva\u2019s attempt to submit a New Drug Application for roluperidone, to treat negative symptoms in schizophrenia. The &hellip; Continue reading &quot;INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Minerva Neurosciences, Inc.\u00a0&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-10T23:00:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDU2MSMzODY2OTEzIzIwMjA2Njk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Minerva Neurosciences, Inc.\u00a0\",\"datePublished\":\"2020-12-10T23:00:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\\\/\"},\"wordCount\":402,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEwMDU2MSMzODY2OTEzIzIwMjA2Njk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\\\/\",\"name\":\"INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Minerva Neurosciences, Inc.\u00a0 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEwMDU2MSMzODY2OTEzIzIwMjA2Njk=\",\"datePublished\":\"2020-12-10T23:00:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEwMDU2MSMzODY2OTEzIzIwMjA2Njk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEwMDU2MSMzODY2OTEzIzIwMjA2Njk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Minerva Neurosciences, Inc.\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Minerva Neurosciences, Inc.\u00a0 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\/","og_locale":"en_US","og_type":"article","og_title":"INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Minerva Neurosciences, Inc.\u00a0 - Market Newsdesk","og_description":"NEW YORK, Dec. 10, 2020 (GLOBE NEWSWIRE) &#8212; The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts on behalf of those who acquired Minerva Neurosciences, Inc. (\u201cMinerva\u201d or the \u201cCompany\u201d) (NASDAQ: NERV) securities during the period from May 15, 2017 through November 30, 2020 (the \u201cClass Period\u201d). Investors have until February 8, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit. On December 1, 2020, Minerva announced the results of its meeting with the U.S. Food and Drug Administration concerning Minerva\u2019s attempt to submit a New Drug Application for roluperidone, to treat negative symptoms in schizophrenia. The &hellip; Continue reading \"INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Minerva Neurosciences, Inc.\u00a0\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-10T23:00:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDU2MSMzODY2OTEzIzIwMjA2Njk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Minerva Neurosciences, Inc.\u00a0","datePublished":"2020-12-10T23:00:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\/"},"wordCount":402,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDU2MSMzODY2OTEzIzIwMjA2Njk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\/","name":"INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Minerva Neurosciences, Inc.\u00a0 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDU2MSMzODY2OTEzIzIwMjA2Njk=","datePublished":"2020-12-10T23:00:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDU2MSMzODY2OTEzIzIwMjA2Njk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDU2MSMzODY2OTEzIzIwMjA2Njk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-minerva-neurosciences-inc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Minerva Neurosciences, Inc.\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/397930","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=397930"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/397930\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=397930"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=397930"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=397930"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}